Oklahoma § 56-4003 - Biomarker testing coverage

Full text of Oklahoma Oklahoma Statutes § 56-4003 — Biomarker testing coverage, with citation guidance and answers to common questions.

§ 56-4003. Biomarker testing coverage

A. As used in this section:

1. "Biomarker", "biomarker testing", "consensus statement", and

"nationally recognized clinical practice guidelines" shall have the

same meaning as provided by Section 1 of this act; and

2. "Contracted entity" shall have the same meaning as provided

by Section 4002.2 of Title 56 of the Oklahoma Statutes.

B. The state Medicaid program shall cover biomarker testing in

accordance with the requirements provided by this section.

C. Biomarker testing shall be covered for the purposes of

diagnosis, treatment, appropriate management, or ongoing monitoring

of a member’s disease or condition when the test is supported by

medical and scientific evidence, including, but not limited to:

Oklahoma Statutes - Title 56. Poor Persons

1. Labeled indications for a United States Food and Drug

Administration (FDA)-approved or -cleared test;

2. Indicated tests for an FDA-approved drug;

3. Warnings and precautions on FDA-approved drug labels;

4. Centers for Medicare and Medicaid Services (CMS) national

coverage determinations or Medicare Administrative Contractor (MAC)

local coverage determinations; or

5. Nationally recognized clinical practice guidelines and

consensus statements.

D. Contracted entities under the state Medicaid program shall

provide biomarker testing at the same scope, duration, and frequency

as the Medicaid program otherwise provides to members.

E. If prior authorization is required for biomarker testing,

the contracted entity shall approve or deny a prior authorization

request and notify the member, the member’s provider, and any entity

requesting authorization of the service within seventy-two (72)

hours for non-urgent requests or within twenty-four (24) hours for

urgent requests.

F. The member and the member’s provider shall have access to

clear, readily accessible, and convenient processes to request an

exception to a coverage policy for biomarker testing of the state

Medicaid program. The process shall be made readily accessible to

all participating providers and members online.

Added by Laws 2023, c. 331, § 3, eff. Jan. 1, 2024.

Frequently Asked Questions About Oklahoma § 56-4003

What does Oklahoma Statutes § 56-4003 cover?

Section 56-4003 ("Biomarker testing coverage") is part of the Oklahoma Statutes, the codified statutory law of Oklahoma. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.

How do I cite Oklahoma § 56-4003?

A common citation format is "Oklahoma Statutes § 56-4003" (Oklahoma). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.

Is this the official text of Oklahoma law?

No. This page is for research and education and may not include the most recent amendments. For official current law, check the Oklahoma official source linked on this page or consult a licensed Oklahoma attorney.

How does Oklahoma § 56-4003 apply to my situation?

Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in Oklahoma can advise on how this section applies to you. Contact your state or local bar association for a referral.

Sources & Verification

Not legal advice. Verify against the official source and consult a licensed attorney in Oklahoma.